| 4.88 0.12 (2.52%) | 12-01 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.61 | 1-year : | 11.56 |
| Resists | First : | 7.37 | Second : | 9.89 |
| Pivot price | 4.29 |
|||
| Supports | First : | 3.28 | Second : | 2.73 |
| MAs | MA(5) : | 4.66 |
MA(20) : | 4.35  |
| MA(100) : | 7.19 |
MA(250) : | 10.76 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 72.6 |
D(3) : | 66.4 |
| RSI | RSI(14): 48.3 |
|||
| 52-week | High : | 23.39 | Low : | 3.28 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MOTS ] has closed below upper band by 15.5%. Bollinger Bands are 21.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.9 - 4.93 | 4.93 - 4.95 |
| Low: | 4.41 - 4.44 | 4.44 - 4.46 |
| Close: | 4.84 - 4.88 | 4.88 - 4.92 |
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Thu, 30 Nov 2023
Healthcare Stocks Moving Thursday: SNGX, NBSE, IMGN, AMPE, VVOS, RDHL, MOTS, ARWR - InvestorsObserver
Wed, 29 Nov 2023
UnitedHealth (UNH) Unveils its Latest Outlook: Key Takeaways - Nasdaq
Tue, 28 Nov 2023
Here's Why Investors Should Hold Cigna (CI) Stock for Now - Nasdaq
Mon, 27 Nov 2023
Is Motus GI Holdings Inc (MOTS) Stock About to Get Hot Monday? - InvestorsObserver
Wed, 22 Nov 2023
What is Wall Street's Target Price for Motus GI Holdings Inc (MOTS) Stock Wednesday? - InvestorsObserver
Mon, 13 Nov 2023
Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 483620 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 10 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.147e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 783.7 % |
| Return on Equity (ttm) | -57.8 % |
| Qtrly Rev. Growth | 364000 % |
| Gross Profit (p.s.) | -38.61 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -26 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.88 |
| Dividend | 0 |
| Forward Dividend | 13320 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|